# Capricor Therapeutics, Inc. (CAPR): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/capr for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

## Quote & Key Metrics

As of 2026-10-22:

| Metric | Value |
|---|---|
| Price | $6.13 USD |
| Market Cap | $355.0M |
| P/E (TTM) | — |
| EPS (TTM) | −$2.45 |
| 52-Week Range | $2.96 – $40.37 |
| Dividend Yield (TTM) | — |

## Dividend

CAPR has no dividend payment history in our records.

## Frequently Asked Questions

### What does Capricor Therapeutics, Inc. do?

Capricor Therapeutics, Inc. (CAPR) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is CAPR's market cap?

Capricor Therapeutics, Inc. (CAPR) has a market capitalization of approximately $355.0 million, as of October 22, 2026, based on the most recent share price and shares outstanding.

### Does CAPR pay a dividend?

No, Capricor Therapeutics, Inc. (CAPR) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is CAPR profitable?

Capricor Therapeutics, Inc. (CAPR) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has CAPR ever paid a dividend?

No. Dividend Data's records show no dividend payments from Capricor Therapeutics, Inc. (CAPR). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/capr
- Dividend history & safety: https://www.dividenddata.com/stocks/capr/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/capr/earnings
- Financial statements: https://www.dividenddata.com/stocks/capr/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/capr/valuation
- Peer comparison: https://www.dividenddata.com/stocks/capr/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.